FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The US Food and Drug Administration has approved lenacapavir (Yeztugo), the first twice-yearly injectable HIV-1 prevention ...

HIV response. Experts are suggesting a projected 24% decrease in HIV funding over the next year in the context of reductions ...

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...

Now, a groundbreaking study from researchers at Boston Children’s Hospital and Harvard Medical School is offering a potential new path forward: using already FDA-approved migraine medications to ...

Four already-approved drugs eased pain and shrank lesions in mice. Doctors share what that could mean for you.

New commitments at Bali forum drive momentum to save hundreds of thousands of girls and women from cancer.Bali, Indonesia, 19 June 2025 - Governments, donors, multilateral institutions, the private ...

Source: Prioritising Zimbabwean children’s future in an uncertain time for global aid UNICEF  One of the greatest joys of my work is meeting Zimbabwean children who inspire me with their ideas, ...